Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.8	84.38	23.76	97.5	194.26
Cash & Short-Term Investments	24.8	84.38	23.76	97.5	194.26
Cash Growth	-70.61%	255.14%	-75.63%	-49.81%	-55.58%
Accounts Receivable	76.83	128.42	60.06	44.86	34.12
Other Receivables	2.97	59.82	2.76	19.56	17.88
Receivables	79.8	188.24	62.82	64.42	52.01
Inventory	95.71	201.89	89.06	61.2	53.53
Other Current Assets	15.91	3.87	330.16	4.86	4.78
Total Current Assets	216.22	478.39	505.8	227.97	304.58
Property, Plant & Equipment	1,062	1,150	633.54	907.87	512.03
Long-Term Investments	51.65	44.75	48.57	59.14	81.09
Goodwill	-	61.6	-	-	-
Other Intangible Assets	125.58	132.21	31.4	40.86	42.08
Long-Term Deferred Tax Assets	11.05	30.96	7.47	9.15	2.67
Long-Term Deferred Charges	12.49	0.8	0.19	2.03	-
Other Long-Term Assets	12.49	66.79	12.9	11.39	30.06
Total Assets	1,492	1,965	1,240	1,258	972.5
Accounts Payable	314.62	310.09	136.11	167.7	80.38
Accrued Expenses	17.21	12.56	7.95	9.79	9.43
Short-Term Debt	160.85	387.77	202.93	156.28	5.01
Current Portion of Long-Term Debt	585.57	85.47	41.71	37.16	20.07
Current Portion of Leases	-	1.31	0.08	0.07	-
Current Income Taxes Payable	-	-	-	-	1.98
Current Unearned Revenue	23.38	1.51	2.81	0.91	3.63
Other Current Liabilities	141.08	131.61	93.54	18.42	6.33
Total Current Liabilities	1,243	930.31	485.14	390.34	126.82
Long-Term Debt	133.92	490.25	105.88	96.99	57
Long-Term Leases	35.47	121.9	45	30.69	-
Long-Term Unearned Revenue	30.02	3.47	4.32	9.63	10.51
Long-Term Deferred Tax Liabilities	3.46	4.96	0.22	8.73	8.23
Other Long-Term Liabilities	70.63	-	-	-	-
Total Liabilities	1,516	1,551	640.56	536.38	202.56
Common Stock	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	349.47	345.46	340.47	340.47	340.47
Retained Earnings	-538.36	-93.5	128.32	250.26	297.78
Treasury Stock	-	-	-32.43	-32.43	-32.43
Comprehensive Income & Other	7.2	3.91	3.91	3.91	3.91
Total Common Equity	-26.27	411.29	595.69	717.63	765.15
Minority Interest	1.73	2.82	3.61	4.4	4.8
Shareholders' Equity	-24.54	414.11	599.3	722.02	769.94
Total Liabilities & Equity	1,492	1,965	1,240	1,258	972.5
Total Debt	915.81	1,087	395.6	321.19	82.08
Net Cash (Debt)	-891.01	-1,002	-371.84	-223.7	112.19
Net Cash Growth	-	-	-	-	-64.44%
Net Cash Per Share	-5.73	-6.51	-2.41	-1.46	0.73
Filing Date Shares Outstanding	155.9	155.42	153.4	153.4	153.4
Total Common Shares Outstanding	155.9	155.42	153.4	153.4	153.4
Working Capital	-1,026	-451.92	20.66	-162.36	177.76
Book Value Per Share	-0.17	2.65	3.88	4.68	4.99
Tangible Book Value	-151.84	217.48	564.29	676.77	723.07
Tangible Book Value Per Share	-0.97	1.40	3.68	4.41	4.71
Buildings	-	479.28	406.53	206.45	194.69
Machinery	-	657.2	585.29	310.2	290.91
Construction In Progress	-	410.78	6.2	709.64	315.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.